2-(3-Isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACJACI684
CAS No. :
1338916-31-6
Molecular Formula :
C16H25BO3
Molecular Weight :
276.18

IUPAC Name:2-(3-isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(3-Isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$123.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(3-isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MDL No.MFCD22494797
Molecular FormulaC16H25BO3
Molecular Weight276.18
SMILESCC1(C)C(C)(C)OB(C2=CC=CC(OCC(C)C)=C2)O1
InChI KeyHSNRUMKHSNHSKT-UHFFFAOYSA-N
Synonym4,4,5,5-tetramethyl-2-[3-(2-methylpropoxy)phenyl]-1,3,2-dioxaborolane;2-(3- Isobutoxyphenyl)-4,4,5,5-tetramethyl-1.3.2-dioxaborolane;1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[3-(2-methylpropoxy)phenyl]-
CAS No.1338916-31-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACJACI684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGBTN426 route compound structure diagram
    ACGBTN426223564-75-8 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACJACI684 route product structure diagram
    ACJACI6841338916-31-6
Inquiry

2. ACJACI684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBQUE625 route compound structure diagram
    ACBQUE625214360-76-6 In Stock
  4. Then
  5. ACJACI684 route product structure diagram
    ACJACI6841338916-31-6
Inquiry

Comments (0)